Commonwealth Equity Services, LLC Tg Therapeutics, Inc. Transaction History
Commonwealth Equity Services, LLC
- $66 Billion
- Q3 2024
A detailed history of Commonwealth Equity Services, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 198,037 shares of TGTX stock, worth $5.38 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
198,037
Previous 186,994
5.91%
Holding current value
$5.38 Million
Previous $3.33 Million
39.22%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding TGTX
# of Institutions
312Shares Held
93MCall Options Held
1.9MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA13.7MShares$372 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$309 Million0.0% of portfolio
-
State Street Corp Boston, MA6.7MShares$182 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.65MShares$99 Million6.57% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.24MShares$88.1 Million0.07% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $3.95B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...